My patients who have completed the treatment showed excellent
results. After following the treatment for 6 months they were no
longer disturbed by their tinnitus and regained their quality of life.
Most of the patients who are undergoing the treatment are showing
very positive progress. It may take longer to complete in some
cases depending on individual issues. Two patients, unfortunately,
have dropped out as they could not fit the treatment into their daily
lives. It takes commitment on the part of the patient to go through
the whole process with the support of the audiologist. The
treatment involves listening to the customised sound processor
(built according to the patient’s hearing and tinnitus profile) for a
minimum of 2 hours a day, together with face to face and telephone
counselling with the audiologist.

Neuromonics is not the only form of tinnitus treatment adopted at
my clinic. Each individual case requires specific approaches. After
12 months experience with the new treatment, I continue to have
no hesitation in recommending it to those patients who meet the
suitability criteria.

We hope that growing credibility based on the success we have
seen so far will increase the numbers of patients going through the
treatment and therefore reduce the cost in the near future.

Does this treatment help tinnitus in Meniere’s disease?

Every individual is different and the characteristic of Meniere’s
disease also varies between different people. It is always worthwhile
going through an assessment to identify an individual’s suitability to
tinnitus treatment.

As a rule of thumb however, most people with Meniere’s disease will
not qualify for the Neuromonics treatment, and there are two basic
reasons for that:

1. The Neuromonics sound processor can only be programmed to
suit hearing losses up to 50dB.

2. The Neuromonics treatment requires stable hearing levels.
In the first and second stages of Meniere’s disease the hearing loss
is usually better than 50dB but not stable - it fluctuates - some days
it is better than others. In the third stage of Meniere’s disease the
hearing no longer fluctuates, it remains stable at a level around 60-
70 dB and therefore outside the hearing range that the
Neuromonics processor can be programmed for.

1 | 2

Home

©2005, Celene McNeill